Drug Channels

MARCH 5, 2024

The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The webinar will last 90 minutes to accommodate audience questions.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

The Pharma Data

NOVEMBER 10, 2020

Growing into a biopharmaceutical company, Innovent has built an integrated platform covering from drug discovery, CMC, clinical development and commercialization. In addition, in order to achieve next level strategic goal of developing global first-in-class product in 5-10 years, Innovent Academy has been established.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

Agency IQ

JUNE 9, 2023

The Orphan Regulation entered into force in January, 2000, outlining requirements for orphan designation and incentives, and establishing the EMA Committee for Orphan Medicinal Products (COMP). Unmet medical need requires the disease to remain associated with high morbidity or mortality if a product is approved for that condition.

Marketing 40

Marketing Regulations Biosimilars Drugs 40

Agency IQ

AUGUST 2, 2024

Additionally, the EMA plans to launch further feature of the SPOR (substance, product, organizational, referential) services. The suite of services aims to harmonize the identification of medicinal products and is being rolled out in an iterative fashion.

Regulations 40

Regulations Clinical Trials Production Trials 40